James Shepherd
Impact in
- Endocrinology, Diabetes and Metabolism top 0.02%
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Surgery top 0.01%
- Lipoproteins and Cardiovascular Health
- Cholesterol and Lipid Metabolism
Papers in
- Surgery 115
- Lipoproteins and Cardiovascular Health 107
- Cholesterol and Lipid Metabolism 16
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 60
- Co-authors
- Christopher J. Packard (67 shared papers)Ian Ford (30 shared papers)Stuart M. Cobbe (18 shared papers)Peter W. Macfarlane (16 shared papers)Antonio M. Gotto (18 shared papers)John J.P. Kastelein (14 shared papers)A R Lorimer (5 shared papers)Christopher Isles (3 shared papers)
- Journals
- Atherosclerosis (20 papers)The American Journal of Cardiology (10 papers)Circulation (9 papers)The Lancet (8 papers)Biochemical Society Transactions (8 papers)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
James Shepherd
177 papers receiving 32.4k citations
James Shepherd's Hit Papers
Peers
Comparison fields: 5 of 187
- Endocrinology, Diabetes and Metabolism 8.6k
- Surgery 16.6k
- Cardiology and Cardiovascular Medicine 5.8k
- Cancer Research 3.4k
- Nephrology 905
Countries citing papers authored by James Shepherd
This map shows the geographic impact of James Shepherd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Shepherd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Shepherd more than expected).
Fields of papers citing papers by James Shepherd
This network shows the impact of papers produced by James Shepherd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Shepherd. The network helps show where James Shepherd may publish in the future.
Co-authors
The 25 scholars most cited alongside James Shepherd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 180 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia Hit paper breakdown → | 1995 | 5964 |
| 2 | Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein Hit paper breakdown → | 2008 | 4956 |
| 3 | Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein Hit paper breakdown → | 2009 | 3018 |
| 4 | Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease Hit paper breakdown → | 2005 | 2597 |
| 5 | Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial Hit paper breakdown → | 2002 | 2526 |
| 6 | Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study Hit paper breakdown → | 2003 | 1240 |
| 7 | Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial Hit paper breakdown → | 2009 | 793 |
| 8 | Plasma Leptin and the Risk of Cardiovascular Disease in the West of Scotland Coronary Prevention Study (WOSCOPS) Hit paper breakdown → | 2001 | 707 |
| 9 | Pravastatin and the Development of Diabetes Mellitus Hit paper breakdown → | 2001 | 694 |
| 10 | Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study Hit paper breakdown → | 2007 | 597 |
| 11 | A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism Hit paper breakdown → | 2009 | 571 |
| 12 | Effects of Dietary Polyunsaturated and Saturated Fat on the Properties of High Density Lipoproteins and the Metabolism of Apolipoprotein A-I Hit paper breakdown → | 1978 | 404 |
| 13 | 2006 | 374 | |
| 14 | 2008 | 374 | |
| 15 | 1997 | 345 | |
| 16 | 2004 | 321 | |
| 17 | 2007 | 309 | |
| 18 | 1980 | 304 | |
| 19 | 2000 | 299 | |
| 20 | 2006 | 294 |
About James Shepherd
James Shepherd is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism, Cancer Research, Economics and Econometrics and Cardiology and Cardiovascular Medicine, having authored 180 papers that have together received 34.4k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (107 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (60 papers), Cancer, Lipids, and Metabolism (30 papers), Health Systems, Economic Evaluations, Quality of Life (20 papers), Cholesterol and Lipid Metabolism (16 papers), Lipid metabolism and disorders (10 papers), Pharmaceutical Economics and Policy (8 papers) and Adipokines, Inflammation, and Metabolic Diseases (7 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (8.6k citations), Surgery (16.6k citations), Cardiology and Cardiovascular Medicine (5.8k citations), Cancer Research (3.4k citations) and Nephrology (905 citations). James Shepherd has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Christopher J. Packard, Ian Ford, Stuart M. Cobbe, Peter W. Macfarlane, Antonio M. Gotto, John J.P. Kastelein, A R Lorimer, Christopher Isles, James H. McKillop and Chris J. Packard. Their work appears in journals such as Atherosclerosis, The American Journal of Cardiology, Circulation, The Lancet and Biochemical Society Transactions.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.